GeneDx Holdings Corp. (NASDAQ:WGS – Get Free Report) CEO Katherine Stueland sold 10,752 shares of the company’s stock in a transaction on Monday, September 18th. The stock was sold at an average price of $4.16, for a total transaction of $44,728.32. Following the completion of the sale, the chief executive officer now owns 42,689 shares […]
GeneDx Holdings Corp. (NASDAQ:WGS – Get Free Report) CFO Kevin Feeley sold 2,742 shares of GeneDx stock in a transaction that occurred on Monday, September 18th. The stock was sold at an average price of $4.16, for a total transaction of $11,406.72. Following the completion of the transaction, the chief financial officer now directly owns […]
Altium Capital Management LP acquired a new position in GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 4,588,000 shares of the company’s stock, valued at approximately $1,675,000. Altium Capital Management LP owned 18.97% of GeneDx at the […]
GeneDx Holdings Corp. (NASDAQ:WGS – Get Free Report) Director Richard C. Pfenniger, Jr. purchased 5,000 shares of the business’s stock in a transaction dated Thursday, August 17th. The stock was bought at an average cost of $5.10 per share, for a total transaction of $25,500.00. Following the purchase, the director now owns 10,918 shares in […]